Quinoxalinas como potenciales agentes Antimycobacterium tuberculosis: una revisión
作者： Elsa Moreno-Viguri , Antonio Monge , Mery Santivañez-Veliz , Silvia Pérez-Silanes
DOI:
关键词: Medicine 、 Quinoxaline 、 Antithrombotic 、 Tuberculosis 、 Biological property 、 Antimycobacterial 、 Pharmacology 、 Antifungal
摘要: Tuberculosis requires of new treatments against their complex resistance as MDR-TB and XDR-TB. Quinoxalines present a wide variety biological properties antichagasic, antimalarial, antileishmanial, antifungal, antibacterial, antiviral, antitumor, anticancer, analgesic, antiinflammatory, antioxidant, antithrombotic antihypertensive. This review shows the approaches for 1,4-di-N-oxide quinoxaline derivatives potential antimycobacterial active agents.
参考文章(54)
Asunción Burguete, Eleni Pontiki, Dimitra Hadjipavlou-Litina, Saioa Ancizu, Raquel Villar, Beatriz Solano, Elsa Moreno, Enrique Torres, Silvia Pérez, Ignacio Aldana, Antonio Monge, Synthesis and Biological Evaluation of New Quinoxaline Derivatives as Antioxidant and Anti-Inflammatory Agents Chemical Biology & Drug Design. ,vol. 77, pp. 255- 267 ,(2011) , 10.1111/J.1747-0285.2011.01076.X
L. G. Wayne, Dormancy ofMycobacterium tuberculosis and latency of disease European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 13, pp. 908- 914 ,(1994) , 10.1007/BF02111491
Esther Vicente, Pablo R Duchowicz, Diego Benítez, Eduardo A Castro, Hugo Cerecetto, Mercedes González, Antonio Monge, None, Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides. Bioorganic & Medicinal Chemistry Letters. ,vol. 20, pp. 4831- 4835 ,(2010) , 10.1016/J.BMCL.2010.06.101
Paolo Sanna, Antonio Carta, Mario Loriga, Stefania Zanetti, Leonardo Sechi, Synthesis of 3,6,7-substituted-quinoxalin-2-ones for evaluation of antimicrobial and anticancer activity. Part 2. Farmaco. ,vol. 54, pp. 161- 168 ,(1999) , 10.1016/S0014-827X(99)00010-5
B. Heym, N. Honoré, C. Schurra, S.T. Cole, B. Heym, C. Truffot-Pernot, J.H. Grosset, A. Banerjee, W.R. Jacobs, J.D.A. van Embden, Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: A molecular study The Lancet. ,vol. 344, pp. 293- 298 ,(1994) , 10.1016/S0140-6736(94)91338-2
Diego Benitez, Mauricio Cabrera, Paola Hernández, Lucía Boiani, María L Lavaggi, Rossanna Di Maio, Gloria Yaluff, Elva Serna, Susana Torres, María E Ferreira, Ninfa Vera de Bilbao, Enrique Torres, Silvia Pérez-Silanes, Beatriz Solano, Elsa Moreno, Ignacio Aldana, Adela López de Ceráin, Hugo Cerecetto, Mercedes González, Antonio Monge, None, 3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies. Journal of Medicinal Chemistry. ,vol. 54, pp. 3624- 3636 ,(2011) , 10.1021/JM2002469
Belén Zarranz, Andrés Jaso, Ignacio Aldana, Antonio Monge, Séverine Maurel, Eric Deharo, Valérie Jullian, Michel Sauvain, Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives Drug Research. ,vol. 55, pp. 754- 761 ,(2011) , 10.1055/S-0031-1296926
Arthur Gomtsyan, Erol K. Bayburt, Robert G. Schmidt, Guo Zhu Zheng, Richard J. Perner, Stanley Didomenico, John R. Koenig, Sean Turner, Tammie Jinkerson, Irene Drizin, Steven M. Hannick, Bryan S. Macri, Heath A. McDonald, Prisca Honore, Carol T. Wismer, Kennan C. Marsh, Jill Wetter, Kent D. Stewart, Tetsuro Oie, Michael F. Jarvis, Carol S. Surowy, Connie R. Faltynek, Chih-Hung Lee, Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties. Journal of Medicinal Chemistry. ,vol. 48, pp. 744- 752 ,(2005) , 10.1021/JM0492958
Edward E. Telzak, Kent Sepkowitz, Peter Alpert, Sharon Mannheimer, Franz Medard, Wafaa El-Sadr, Steve Blum, A. Gagliardi, Nadim Salomon, Glenn Turett, Multidrug-Resistant Tuberculosis in Patients without HIV Infection The New England Journal of Medicine. ,vol. 333, pp. 907- 912 ,(1995) , 10.1056/NEJM199510053331404
J. P. Kleim, M. Rosner, I. Winkler, A. Paessens, R. Kirsch, Y. Hsiou, E. Arnold, G. Riess, Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 34- 38 ,(1996) , 10.1073/PNAS.93.1.34